Liposomes for brain delivery

被引:89
作者
Lai, Francesco [1 ]
Fadda, Anna Maria [1 ]
Sinico, Chiara [1 ]
机构
[1] Univ Cagliari, Dipartimento Sci Vita & Ambiente, I-09124 Cagliari, Italy
关键词
blood-brain barrier; drug delivery; immunoliposomes; liposomes; receptor-mediated transcytosisort; transport routes across the BBB; ANTITRANSFERRIN RECEPTOR ANTIBODY; HUMAN INSULIN-RECEPTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; STERICALLY STABILIZED LIPOSOMES; CAPILLARY ENDOTHELIAL-CELLS; LONG-CIRCULATING LIPOSOMES; TAT-MODIFIED CHOLESTEROL; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR RECEPTOR; DRUG-DELIVERY;
D O I
10.1517/17425247.2013.766714
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Development of drug delivery systems for brain delivery is one of the most challenging research topics in pharmaceutical areas, mainly due to the presence of the blood-brain barrier (BBB), which separates the blood from the cerebral parenchyma thus limiting the brain uptake of the majority of therapeutic agents. Among the several carriers, which have been studied to overcome this problem, liposomes have gained increasing attention as promising strategies for brain-targeted drug delivery. The most advantageous features of liposomes are their ability to incorporate and deliver large amounts of drug and the possibility to decorate their surface with different ligands. Areas covered: The purpose of this review is to explore the different approaches studied to transport and deliver therapeutics and imaging agents to the brain by using liposomes. In the first part of the review, particular attention is paid to describe the anatomy of the BBB and different physiological transport mechanisms available for drug permeation. In the second part, the different strategies for the delivery of a drug to the brain using liposomes are reviewed for each transport mechanism. Expert opinion: Over the last decade, there have been significant developments concerning liposomal brain delivery systems conjugated with selected ligands with high specificity and low immunogenicity. An universally useful liposomal formulation for brain targeting does not exist but liposome design must be modulated by the appropriate choice of the specific homing device and transport mechanism.
引用
收藏
页码:1003 / 1022
页数:20
相关论文
共 145 条
  • [11] IN-VIVO DEMONSTRATION OF SUBCELLULAR-LOCALIZATION OF ANTITRANSFERRIN RECEPTOR MONOCLONAL ANTIBODY-COLLOIDAL GOLD CONJUGATE IN BRAIN CAPILLARY ENDOTHELIUM
    BICKEL, U
    KANG, YS
    YOSHIKAWA, T
    PARDRIDGE, WM
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1994, 42 (11) : 1493 - 1497
  • [12] Delivery of peptides and proteins through the blood-brain barrier (Reprinted from Advanced Drug Delivery Reviews, vol 10, pg 205-245, 1993)
    Bickel, U
    Yoshikawa, T
    Pardridge, WM
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) : 247 - 279
  • [13] Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier
    Boado, Ruben J.
    Zhang, Yufeng
    Zhang, Yun
    Pardridge, William M.
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 2007, 96 (02) : 381 - 391
  • [14] CONVECTION-ENHANCED DELIVERY OF MACROMOLECULES IN THE BRAIN
    BOBO, RH
    LASKE, DW
    AKBASAK, A
    MORRISON, PF
    DEDRICK, RL
    OLDFIELD, EH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) : 2076 - 2080
  • [15] TRANSCYTOTIC PATHWAY FOR BLOOD-BORNE PROTEIN THROUGH THE BLOOD-BRAIN BARRIER
    BROADWELL, RD
    BALIN, BJ
    SALCMAN, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (02) : 632 - 636
  • [16] Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
    Bu, Guojun
    [J]. NATURE REVIEWS NEUROSCIENCE, 2009, 10 (05) : 333 - 344
  • [17] ELECTRICAL-RESISTANCE ACROSS THE BLOOD-BRAIN-BARRIER IN ANESTHETIZED RATS - A DEVELOPMENTAL-STUDY
    BUTT, AM
    JONES, HC
    ABBOTT, NJ
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1990, 429 : 47 - 62
  • [18] Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight
    Camenisch, G
    Alsenz, J
    van de Waterbeemd, H
    Folkers, G
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 6 (04) : 313 - 319
  • [19] Looking at the blood-brain barrier: Molecular anatomy and possible investigation approaches
    Cardoso, Filipa Lourenco
    Brites, Dora
    Brito, Maria Alexandra
    [J]. BRAIN RESEARCH REVIEWS, 2010, 64 (02) : 328 - 363
  • [20] Nanoparticulate Devices for Brain Drug Delivery
    Celia, Christian
    Cosco, Donato
    Paolino, Donatella
    Fresta, Massimo
    [J]. MEDICINAL RESEARCH REVIEWS, 2011, 31 (05) : 716 - 756